Skip to main content
OpenTrials
Completed

NCT Number: NCT05060575

Hypertension Patients on Drug Medication Adherence and Rational Medication Use

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hacer GÖK UĞUR

Ordu, Cumhuriyet Campus Cumhuriyet District, 52200, Turkey (Türkiye)

About this study

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use.

Research Hypotheses H0: Education and telephone counseling given to hypertension patients do not affect drug treatment compliance.

H1: Education and telephone counseling given to hypertension patients increase drug treatment compliance.

H0: Education and telephone counseling given to hypertension patients do not affect rational drug use.

H1: Education and telephone counseling given to hypertension patients increase rational drug use.

This study was planned as a single-blind randomized controlled experimental study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Diagnosed with hypertension,
  • Hypertension disease duration of at least 6 months,
  • Using at least one drug due to hypertension,
  • 18 years old and over
  • Literate,
  • Living in the town centre,
  • Owns a phone
  • Open to communication and cooperation,
  • Patients willing to participate in the study will be included in the study.

Exclusion criteria

  • Having a psychiatric illness
  • Hearing loss,
  • Can't understand or speak Turkish and
  • Patients who do not wish to continue the study will be excluded from the study.

Treatment and study plan

Education and Telephone Counceling

Other

Drug use and rational drug use training will be given to hypertension patients in the experimental group.

The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.

Primary outcomes

  1. Adherence to Medication Self-Efficacy Scale

    Time frame: 12 weeks

    The scale consists of 13 items and determines the self-efficacy/confidence level of adherence to drug treatments of individuals with hypertension. The scale is evaluated by scoring from 1 to 4 in each question. The minimum score that can be obtained from the scale is 13, and the maximum score is 52. The increase in the scale score indicates that the compliance of individuals to antihypertensive drug treatment increases positively.

  2. Rational Drug Use Scale

    Time frame: 12 weeks

    The scale has 36 items and is a triple Likert type. Behavioral beliefs (items 1-9), Control beliefs (items 10-16), Attitude (items 17-21), Subjective norm (items 22-23), Intention (items 24-28), and Knowledge It has 6 sub-dimensions (items between 29 and 36). Scoring of scale items was never (0), sometimes (1), and always (2) for positive items; negative items (items 13, 14, 17, 18, 19, 20, 21, and 24) are calculated as never (2), sometimes (1), and always (0). The scores that can be obtained from the scale range from 0 to 72. As the score obtained from the scale increases, the level of rational drug use increases.

Secondary outcomes

  1. Diastolic/Systolic blood pressure

    Time frame: 12 weeks

    Systolic and Diastolic blood pressure will be measured.

Sponsors and collaborators

Lead sponsor

Ordu University

Other

Registry information

Official study title

The Effect of Education and Telephone Counseling Given to Hypertension Patients on Drug Medıcation Adherence and Rational Medication Use: Single-Blind Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Sep 29, 2021
Registry last updated
Oct 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.